This Altcoin Launches Million Dollar Fund: Price Jumps! –

Announcing that it has launched a $150 million ecosystem fund, a Cosmos-based altcoin project gained double-digit value in a short time after the news.

Cosmos-based altcoin flies on $150M funding news

Injective (INJ), the Cosmos-based L1 Blockchain that creates DeFi applications that can access other blockchains, has announced a $150 million ecosystem initiative with partners including crypto investment firms Pantera Capital and Kucoin Ventures, market maker Jump Crypto, and research and development center Delphi Labs. The fund will support projects that accelerate the adoption of interoperable infrastructure and decentralized finance (DeFi).

Eric Chen, CEO and co-founder of the platform, said of the $150 million ecosystem initiative, “We’ve seen many ecosystem funds do various things in the past, but there was no established ecosystem fund for Injective and Cosmos as a whole. We call it a venture consortium because they can receive investment from there or directly from institutions.”

Injective debuted on launchpad by Binance Labs in 2018 and was later backed by Jump Crypto, Pantera Capital, and billionaire entrepreneur Mark Cuban. In the third quarter of 2022, it received corporate funding from Brevan Howard and Jump. Its ecosystem works with decentralized applications (dApps) such as Coinbase, Figment, Pyth, and Wormhole, to name a few.

The new ecosystem will now offer funding initiative, token and equity investments, and provide operational support through memberships in development, cryptographic research, marketing and community growth. New York-based Injective is also launching a global virtual hackathon where developers can submit projects for potential venture funding.

The ecosystem fund is backed by a number of high-profile companies

The new ecosystem fund is supported by previous investors such as Pantera and Jump, as well as other Web3 players such as Kraken Ventures, Kucoin Ventures, Delphi Labs, Flow Traders, Gate Labs and IDG Capital. Injective CEO Chen said $150 million is raised capital from the consortium and will be deployed “in a few years.”

The investor group aims to support projects built on Injective or Cosmos in the interoperability, DeFi, commerce, staking infrastructure and scalability solutions industries.

Injective (INJ) price gained 20% after the announcement

Ranking 163rd by market cap, the altcoin rallied over 20% after the announcement made on Twitter about two hours ago. INJ is currently trading at $2.26 and ATH price has a long way to go at $25.01.

cryptocoin.comAs you follow, Polygon (MATIC) and QuickNode were also on the agenda with important partnership and investment news recently.

Contact us to be instantly informed about the last minute developments. twitterin, Facebookin and InstagramFollow and Telegram and YouTube join our channel!

Risk Disclosure: The articles and articles on do not constitute investment advice. Bitcoin and cryptocurrencies are high-risk assets, and you should do your due diligence and do your own research before investing in these currencies. You can lose some or all of your money by investing in Bitcoin and cryptocurrencies. Remember that your transfers and transactions are at your own risk and any losses that may occur are your responsibility. does not recommend buying or selling any cryptocurrencies or digital assets, nor is an investment advisor. For this reason, and the authors of the articles on the site cannot be held responsible for your investment decisions. Readers should do their own research before taking any action regarding the company, assets or services in this article.

Disclaimer: Advertisements on are carried out through third-party advertising channels. In addition, also includes sponsored articles and press releases on its site. For this reason, advertising links directed from are on the site completely independent of’s approval, and visits and pop-ups directed by advertising links are the responsibility of the user. The advertisements on and the pages directed by the links in the sponsored articles do not bind in any way.

Warning: Citing the news content of and quoting by giving a link is subject to the permission of No content on the site can be copied, reproduced or published on any platform without permission. Legal action will be taken against those who use the code, design, text, graphics and all other content of in violation of intellectual property law and relevant legislation.

Show Disclaimer

source site-3